Firms

Seaside Ventures

Seaside Ventures

United States (own current brand) · 1802 Canyon Blvd, Boulder, Colorado80302 (historical April25,2022 SECfund/managerfiling address)

seasideventures.comlinkedin.com

Seaside Ventures is the US early-stage health and wellness venture manager operating seasideventures.com, distinct from protected Seaside Equity Partners Investor4613 and from unrelated therapeutics companies. Exact regulatory/filing identity is Seaside Ventures Management, LLC, CRD317945. Its March31,2025 primary SEC FormADV identifies that legal adviser; the exact FormD of Delaware Seaside Ventures FundI LP (CIK1904117, organised2021) identifies the management company, Seaside Ventures FundI GP LLC and Harrison Valner as manager of the fund general partner. Adviser identity is not an inference that the platform is a different registered bank, fund or manager. No unsupported exact manager founding date or current SEC-registration status is asserted. Seaside focuses on science-driven consumer health, commercialisation and preventive personalised care. Own public thesis covers brain health and cognition, physical and mental wellbeing, and translating validated innovations into accessible products. Own contact FAQ says idea-stage through seed, typicallyUSD250K, with UnitedStates/Canada/Europe geography; the broader about page lists incubation, preseed, seed and SeriesA. These strategy ranges are not individual disclosed tickets. Its Seaside Syndicate provides accredited participants with deal-specific SPVs alongside FundI or laterstage opportunities. Syndicate minimums, average-size marketing and deployment targets are not actual closed LP funds or fresh issuer cash; no duplicate fund/manager/personal check is inferred. The published core team is managing partners Harrison Valner and Ryan Roddy and operating partner Derek Callow, all with genuine individually named own portraits and substantive biographies. Own external-adviser directory lists nine humans separately from investment staff: Matt Johnson, Ben Greenfield, Ryan Greene, Nicola Munarini, Ben Van de Bunt, Matthew Jung, Kevin Sprouse, Timothy Mohn and Alexander Jutkowitz. Their titles denote external expertise, not Seaside employment or personal investment subscriptions. The dog Diego is a mascot, not a Person. The existing ThisLife cofounder MattJohnson has a possible connection to the own Seaside adviser who links to TheFeed’s MattJ professional profile, but a sufficient primary career/identity bridge was not established. That protected Person remains unchanged; the uncertain adviser identity is documented rather than silently merged or duplicated. Eight other human adviser affiliations are imported with own published capacities; seven have authentic portraits and Timothy Mohn’s cartoon avatar is rejected; detailed independent career biographies are not published in the manager directory. Unknownappointment dates remainNULL. The own SF/NY office section retains obvious InvestorX template addresses, investorx.com contact emails and named template stock photos. These are rejected as actual manager offices. The historical2022 SECaddress in Boulder is qualified with its filingdate; no present headquarters is inferred from a template. The logo is original individually captioned official SeasideVenturesLogo, and uploaded team images are authentic own-source photographs, visually checked, with no fabricated faces. FundI’s April25,2022 original FormD records indefinite offering and zero sold beforefirstsale. A later managing-partner own announcement says firstclose completed and initialcapitalcalled, while explicitlycallingUSD10M a target, not a proved finalclose. Accordingly exactclosedsize and announcementday remainNULL. FundI is a distinct verified legalpartnership, not a secondmanager. SubsequentSPVs/currentadditionallegalfunds, GAV/AUM and exactfullfinalclose are unproven and not invented. Own portfolio confirms neural sleep headband Somnee, menstrual-neurotechnology Samphire Neuroscience, AIneurological-drug-discovery PangeaBio, reinforcement-learning ICU dosing Strive, AI-enabled microbiome infrastructure BiomeSense and aptamer biosensor Adaptyx alongside other health/biotech/materials businesses. Twenty-three own portfolio cards are queued for fullissuer identity/clinical/funding audits. Portfolio product/approval assertions are source-published marketing, not independently verified regulatory or clinical outcomes. The Samphire portfolio’s Preseed2023 card and uniformly2025 investor-page dates are classification/content fields, not financing dates. Actualtransaction counsel names Seaside among participants in Samphire’s USD2.3Mpreseed publiclyannouncedFebruary2024; issuer owner retainsone source-qualifiedactualparticipation with ticketNULL, noUSD250Kdefault or personalHarry/Ryancheck. The Fortify managing partner’s own announcement independently names Seaside as an existing-investor participant in Samphire’s actual USD5M2025 seed financing (retained issuer event publiclyannouncedJune5,2025). This is distinct from the actual2024preseed and is not inferred from the portfolio’s inconsistent calendar fields. The company-profile owner adds exactlyoneundisclosed-ticket nonlead follow-on; exactsubscriptionvehicle and fund/person allocation remainunpublished.

Founded
—
Type
Venture capital

Funds1

  • Seaside Ventures Fund I, LP—

    ExactDelawareventurelimitedpartnership CIK1904117 organised2021; GPSeasideVenturesFundIGPLLC, managerSeasideVenturesManagementLLC. OriginalApril25,2022FormDindefiniteoffering/0sold beforefirstsale; laterownpartnerreports actualfirstclose andcapitalcalled but10MexplicitTARGET only. Exactfinalsize andannouncementdayunprovedNULL, no10Mcompletedcashguess. SyndicateSPVs notduplicatefundraise.

Team

Operations and support

Alexander JutkowitzAlexander JutkowitzExternal Adviser — Founder & Growth Investor
Ben GreenfieldBen GreenfieldExternal Adviser — Biohacker & Human Performance Expert
Ben Van de BuntBen Van de BuntExternal Adviser — Founder & CEO
Derek CallowDerek CallowOperating Partner
Harrison ValnerHarrison ValnerManaging Partner
Kevin SprouseKevin SprouseExternal Adviser — Sports Physician
Matthew JungMatthew JungExternal Adviser — Founder & CEO
Nicola MunariniNicola MunariniExternal Adviser — VC partner
Ryan GreeneRyan GreeneExternal Adviser — Medical Director
Ryan RoddyRyan RoddyManaging Partner
Timothy MohnExternal Adviser — CTO & Advisor

Co-investing

Investments